Joseph Lotem

11.2k total citations · 1 hit paper
111 papers, 9.4k citations indexed

About

Joseph Lotem is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Joseph Lotem has authored 111 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 42 papers in Oncology and 39 papers in Hematology. Recurrent topics in Joseph Lotem's work include Acute Myeloid Leukemia Research (36 papers), Cancer-related Molecular Pathways (19 papers) and Cytokine Signaling Pathways and Interactions (19 papers). Joseph Lotem is often cited by papers focused on Acute Myeloid Leukemia Research (36 papers), Cancer-related Molecular Pathways (19 papers) and Cytokine Signaling Pathways and Interactions (19 papers). Joseph Lotem collaborates with scholars based in Israel, United States and Sweden. Joseph Lotem's co-authors include Leo Sachs, Adi Kimchi, Moshe Oren, Elisheva Yonish-Rouach, Yoram Groner, Ditsa Levanon, Gad Asher, Yosef Shaul, Varda Negreanu and Y Shabo and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Joseph Lotem

110 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

1991 1.8k citations Joseph Lotem, Leo Sachs et al. profile →

Peers

Countries citing papers authored by Joseph Lotem

Since Specialization

Citations

This map shows the geographic impact of Joseph Lotem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Lotem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Lotem more than expected).

Fields of papers citing papers by Joseph Lotem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Lotem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Lotem. The network helps show where Joseph Lotem may publish in the future.

Co-authorship network of co-authors of Joseph Lotem

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Lotem. A scholar is included among the top collaborators of Joseph Lotem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Lotem. Joseph Lotem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Runx3, Brn3a and Isl1 interplay orchestrates the transcriptional program in the early stages of proprioceptive neuron development 2024 ·PLoS Genetics ·Kira Orlovsky, Elena Appel, Shay Hantisteanu, Tsviya Olender, Joseph Lotem, Ditsa Levanon, Yoram Groner	1
2	The Leo Sachs’ legacy: a pioneer’s journey through hematopoiesis 2017 ·The International Journal of Developmental Biology ·Joseph Lotem, Yoram Groner	1
3	Carcinogen-Induced Skin Tumor Development Requires Leukocytic Expression of the Transcription Factor Runx3 2014 ·Cancer Prevention Research ·(unknown), Shay Hantisteanu, Joseph Lotem, Yoram Groner	6
4	Addiction of t(8;21) and inv(16) Acute Myeloid Leukemia to Native RUNX1 2013 ·Cell Reports ·(unknown), Dan Friedman, Dena Leshkowitz, Dalia Goldenberg, Kira Orlovsky, Niv Pencovich, Joseph Lotem, Amos Tanay, Yoram Groner	103
5	Cell-Autonomous Function of Runx1 Transcriptionally Regulates Mouse Megakaryocytic Maturation 2013 ·PLoS ONE ·Niv Pencovich, (unknown), (unknown), (unknown), Joseph Lotem, Amos Tanay, Yoram Groner	20
6	Genes overexpressed in different human solid cancers exhibit different tissue-specific expression profiles 2007 ·Proceedings of the National Academy of Sciences ·Jacob Bock Axelsen, Joseph Lotem, Leo Sachs, Eytan Domany	52
7	Developmentally regulated promoter-switch transcriptionally controls Runx1function during embryonic hematopoiesis 2007 ·BMC Developmental Biology ·Amir Pozner, Joseph Lotem, Cuiying Xiao, Dalia Goldenberg, Ori Brenner, Varda Negreanu, Ditsa Levanon, Yoram Groner	57
8	Regulation of Leukaemic Cells by Interleukin 6 and Leukaemia Inhibitory Factor 2007 ·Novartis Foundation symposium ·Joseph Lotem, Leo Sachs	0
9	Epigenetics and the plasticity of differentiation in normal and cancer stem cells 2006 ·Oncogene ·Joseph Lotem, Leo Sachs	67
10	Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1 2002 ·Proceedings of the National Academy of Sciences ·Gad Asher, Joseph Lotem, Leo Sachs, Chaim Kahana, Yosef Shaul	174
11	Cytokine control of developmental programs in normal hematopoiesis and leukemia 2002 ·Oncogene ·Joseph Lotem, Leo Sachs	100
12	Epigenetics wins over genetics: induction of differentiation in tumor cells 2002 ·Seminars in Cancer Biology ·Joseph Lotem, Leo Sachs	54
13	Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis 2001 ·Mechanisms of Development ·Ditsa Levanon, Ori Brenner, Varda Negreanu, David Bettoun, Eilon Woolf, Raya Eilam, Joseph Lotem, Uri Gat, Florian Otto, Nancy A. Speck, Yoram Groner	162
14	The RUNX3 gene – sequence, structure and regulated expression 2001 ·Gene ·(unknown), Nir Rubins, Gustavo Glusman, Yael Bernstein, Varda Negreanu, Dalia Goldenberg, Joseph Lotem, Edna Ben‐Asher, Doron Lancet, Ditsa Levanon, Yoram Groner	160
15	Cytokines as suppressors of apoptosis 1999 ·APOPTOSIS ·Joseph Lotem, Leo Sachs	32
16	Expression of AML1-d, a short human AML1 isoform, in embryonic stem cells suppresses in vivo tumor growth and differentiation 1998 ·Cell Death and Differentiation ·(unknown), Ditsa Levanon, (unknown), Debora Kidron, Dalia Goldenberg, Joseph Lotem, (unknown), Yoram Groner	27
17	A Large Variety of Alternatively Spliced and Differentially Expressed mRNAs Are Encoded by the Human Acute Myeloid Leukemia Gene AML1 1996 ·DNA and Cell Biology ·Ditsa Levanon, Yael Bernstein, Varda Negreanu, (unknown), Irit Bar‐Am, (unknown), Dalia Goldenberg, Joseph Lotem, Yoram Groner	85
18	The Molecular Regulators of Macrophage and Granulocyte Development 1989 ·Annals of the New York Academy of Sciences ·Leo Sachs, Joseph Lotem, Y Shabo	31
19	Target‐cell specificity of hematopoietic regulatory proteins for different clones of myeloid leukemic cells: Two regulators secreted by krebs carcinoma cells 1988 ·International Journal of Cancer ·Y Shabo, Joseph Lotem, Leo Sachs	14
20	Regulation of cap formation by concanavalin A and the differentiation of myeloid leukemic cells 1976 ·Experimental Cell Research ·Joseph Lotem, Israël Vlodavsky, Leo Sachs	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact